eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
PTPI Petros Pharmaceuticals
- 0.0120
- -0.0010-7.69%
Close Apr 30 16:00 ET
- 0.0119
- -0.0001-0.83%
Post 19:10 ET
642.23KMarket Cap0.00P/E (TTM)
0.0169High0.0105Low656.83MVolume0.0161Open0.0130Pre Close8.61MTurnover1276.87%Turnover Ratio0.00P/E (Static)53.52MShares0.720052wk High-0.09P/B617.29KFloat Cap0.010552wk Low--Dividend TTM51.44MShs Float59.5990Historical High--Div YieldTTM49.23%Amplitude0.0105Historical Low0.0130Avg Price1Lot Size
Petros Pharmaceuticals Key Stats
EPS
According to the latest financial report of Petros Pharmaceuticals, the latest earnings per share (TTM) for the company is -29.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Petros Pharmaceuticals's free cash flow? The latest report shows it as 959.96K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Petros Pharmaceuticals shows that the company's current ratio is 0.40, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Petros Pharmaceuticals, the quick ratio is 0.23, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Petros Pharmaceuticals? The latest ROE figure is -93.81%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Petros Pharmaceuticals, the total asset return on investment (ROA) is -68.87%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Petros Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 63.50%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Petros Pharmaceuticals, the net profit margin is -1.28K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀